Refine Results
- Content Type
-
Content Type
- Analysis Platform
-
Product
- Language
-
Language
Applied Filters
Recently updated Cancer Immunotherapy Handbook featuring the latest high impact xCELLigence publications and newly released supporting information.
- Publication Part Number: 5994-1303EN
- Created: 08 July 2025
- 6 MB
In this application note, a series of experiments demonstrates how the xCELLigence system may be used to monitor functional activation of GPCRs in living cells.
- Publication Part Number: 5994-1692EN
- Created: 02 Feb 2021
- 1 MB
Dell Ownership transferring process
- Created: 24 Aug 2020
- 417 KB
An assay workflow demonstration measuring cytotoxic T lymphocyte-mediated destruction of tumor cells and the corresponding secretion of cytokines using an Agilent xCELLigence and NovoCyte flow cytometer instrument.
- Publication Part Number: 5994-1022EN
- Created: 01 Nov 2019
- 601 KB
A compilation of studies demonstrating the application of xCELLigence RTCA to the analysis of bacterial toxins, biofilms, virus titer determination, and other areas of disease.
- Publication Part Number: 5994-1084EN
- Created: 01 Nov 2019
- 5 MB
A collection of studies showing the benefits of xCELLigence RTCA assays over traditional assays. Antiviral drugs, virucides, neutralizing antibodies and other applications are examined.
- Publication Part Number: 5994-1086EN
- Created: 01 Nov 2019
- 4 MB
This editorial showcases Agilent solutions for metabolic modulation enhancing CAR T-cell activation, persistence, and serial killing for improved cancer immunotherapy
- Publication Part Number: 5994-7739EN
- Created: 04 Nov 2024
- 830 KB